Journey Medical (DERM)

• Market cap: $220M
• 1 day: 3.08%
• 5 days: 3.85%
• 1 month: 14.19%
• 3 months: 17.23%
• 6 months: 21.83%
• Year to date: 109.25%
• 1 year: 57.33%
• 5 years: -11.89%
• 10 years: -11.89%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Employees: 41